drugset / Trial / NCT02136940
Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this parallel group study is to evaluate the safety, tolerability and efficacy of AMA0076 in reduction of intraocular pressure in subjects with primary open-angle glaucoma or ocular hypertension.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-11
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMA0076 | Unknown | 0.1 % | Topical |
| Subject | AMA0076 | Unknown | 0.25 % | Topical |
| Subject | AMA0076 | Unknown | 0.5 % | Topical |